FMC Corporation (NYSE: FMC) Price Target Lowered Amid Debt Reduction Efforts

• BMO Capital lowered its price target for FMC Corporation (NYSE: FMC) to $14.00 from $15.00, while keeping a Market Perform rating on the stock.
• With FMC recently trading at $11.35, the new target still implies potential upside of approximately 23.35%.

FMC is a global agricultural sciences company that develops crop protection products, including herbicides, insecticides, fungicides, biologicals, and crop nutrition solutions. The company has been under pressure due to weak market conditions, debt concerns, and a sharp decline in its share price over the past year.

To improve its financial position, FMC has entered into a definitive agreement with Tessenderlo Group for an approximately $400 million minority equity investment. Under the agreement, Tessenderlo will purchase FMC shares at $13.30 per share and, upon completion, will own approximately 20% of FMC’s outstanding common stock.

FMC plans to use the proceeds from the Tessenderlo investment to reduce debt and support its broader target of approximately $1 billion in debt paydown. The transaction is subject to customary closing conditions, including regulatory approvals.

The company is also pursuing additional balance sheet actions. FMC recently entered into a framework agreement for a $114 million sale-leaseback of its Newark, Delaware property. The company expects to continue operating its global R&D headquarters at the Stine Research Center after the transaction, while using proceeds from the deal to further reduce debt.

FMC currently has a market capitalization of about $1.42 billion. Although the stock is trading near its 52-week low, the company’s debt reduction efforts, strategic investment from Tessenderlo, and focus on its crop protection pipeline may support its long-term recovery potential.